Quick Dispatch:
Your nct foxo4-dri Heterogeneity of Cellular Senescence, Senotyping, and Targeting by Senolytics and Senomorphics in Lung Diseases orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your nct foxo4-dri Heterogeneity of Cellular Senescence, Senotyping, and Targeting by Senolytics and Senomorphics in Lung Diseases ships.
Need Help?
Questions about nct foxo4-dri Heterogeneity of Cellular Senescence, Senotyping, and Targeting by Senolytics and Senomorphics in Lung Diseases, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for nct foxo4-dri Heterogeneity of Cellular Senescence, Senotyping, and Targeting by Senolytics and Senomorphics in Lung Diseases in your area.
PDF) The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI
21.60
TRANSLATING THE BIOLOGY OF AGING INTO NEW THERAPEUTICS FOR ALZHEIMER'S DISEASE: SENOLYTICS • The Journal of Prevention of Alzheimer's Disease
20.17
PDF) The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI
28.58
TRANSLATING THE BIOLOGY OF AGING INTO NEW THERAPEUTICS FOR ALZHEIMER'S DISEASE: SENOLYTICS • The Journal of Prevention of Alzheimer's Disease
21.22
Cellular Senescence in Kidney Diseases: From Bench to Clinic - Shu - 2025 - The FASEB Journal
24.73
Cellular Senescence in Kidney Diseases: From Bench to Clinic - Shu - 2025 - The FASEB Journal
29.96
The FOXO4 peptide in a DRI conformation (D-amino acids in a retro-reversed sequence), henceforth named FOXO4-DRI, competes with FOXO4 for p53 binding in a dose-dependent manner and doing so with higher affinity
22.72
